Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multicenter Phase II Study of Fluorouracil, Leucovorin, Oxaliplatin, and Irinotecan (FOLFOXIRI) in Patients With Locally Advanced or Metastatic Biliary Tract Cancer

NCT01494363 is registered in ClinicalTrials.gov with Soon Chun Hyang University as lead sponsor.

NCT NCT01494363
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01494363 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multicenter Phase II Study of Fluorouracil, Leucovorin, Oxaliplatin, and Irinotecan (FOLFOXIRI) in Patients With Locally Advanced or Metastatic Biliary Tract Cancer
Lead sponsor
Soon Chun Hyang University
Phase
Phase 2
Overall status
Unknown status
Start date
October 31, 2011
Completion date
December 31, 2013
Enrollment
53 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

biliary tract cancer